The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
200 jobs Number of planned job losses
Announcement Date
7 September 2004
Employment effect (start)
Foreseen end date
31 December 2004
Description
The Dutch consortium MEI Beheer, Het Tsjechie en Slowakije Fonds N.V. and entrepreneur Petrus Hermannus Maria Winkelman achieved in summer the majority share ownership in Biotika in Slovenská LupÄa, which is one of the most important pharmaceutical company in Slovakia. The owners decided for further staff reductions in the company. Before the end of 2004 about 200 employees are planned to be dismissed, 130 of whom have already left the company.
Sources
7 September 2004: SME
Citation
Eurofound (2004), Biotika, Internal restructuring in Slovakia, factsheet number 60516, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/60516.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
